---
title: "Dyne Therapeutics to Participate in Upcoming Investor Conferences"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286254825.md"
description: "In Waltham, Massachusetts, on May 13, 2026, Dyne Therapeutics, Inc. (Nasdaq: DYN), which specializes in developing treatments for individuals with genetically driven neuromuscular disorders, revealed plans for their involvement in upcoming investor conferences."
datetime: "2026-05-13T11:31:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286254825.md)
  - [en](https://longbridge.com/en/news/286254825.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286254825.md)
---

# Dyne Therapeutics to Participate in Upcoming Investor Conferences

In Waltham, Massachusetts, on May 13, 2026, Dyne Therapeutics, Inc. (Nasdaq: DYN), which specializes in developing treatments for individuals with genetically driven neuromuscular disorders, revealed plans for their involvement in upcoming investor conferences.

### Related Stocks

- [DYN.US](https://longbridge.com/en/quote/DYN.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Dyne Therapeutics (NASDAQ:DYN) CEO John Cox Sells 3,311 Shares](https://longbridge.com/en/news/286472443.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [Zydus buys US specialty drugmaker Assertio in Rs 1,600 crore all-cash deal](https://longbridge.com/en/news/286352725.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)